Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Administration of Intravenous or Paravertebral Lidocaine in Continuous Perfusion During the Intraoperative Period of Lung Resection Surgery on the Appearance of Postoperative Complications

NCT03905837 is registered in ClinicalTrials.gov with Francisco Andres de la Gala as lead sponsor.

NCT NCT03905837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03905837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Administration of Intravenous or Paravertebral Lidocaine in Continuous Perfusion During the Intraoperative Period of Lung Resection Surgery on the Appearance of Postoperative Complications
Lead sponsor
Francisco Andres de la Gala
Phase
Phase 4
Overall status
Completed
Start date
January 28, 2019
Completion date
July 2, 2021
Enrollment
156 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung diseases, lung inflammation, lung injury, acute, postoperative complications